Boston Scientific Corp (MIL:1BSX)
€ 85.5 0 (0%) Market Cap: 126.98 Bil Enterprise Value: 135.61 Bil PE Ratio: 74.26 PB Ratio: 6.39 GF Score: 56/100

Boston Scientific Corp at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 03:00PM GMT
Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research

Good to go here. Thanks, everybody, for coming out early. Las Vegas time anyway. I'm Bob Hopkins from BofA, and I want to say thank you very much to the Boston Scientific team for being here this morning. This is a fireside chat format. We have Dan Brennan, obviously, the company's Chief Financial Officer; and Susie Lisa, who runs Investor Relations. And just thrilled to have you guys here. Thank you.

Susan Vissers Lisa
Boston Scientific Corporation - VP of IR

Thanks, Bob.

Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO

Pleasure to be here. Thanks for the invite.

Robert Adam Hopkins;Daniel J. Brennan
BofA Merrill Lynch, Research Division - MD of Equity Research;Boston Scientific

Dan, I don't know if there's a quick opening kind of message you want to deliver, or we'll just hop right into Q&A. Either way is fine with me.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot